英文名稱 Anti-B7H4

中文名稱 B7-H4抗體

濃 度 1mg/1ml

規(guī) 格 0.1ml/100μg 0.2ml/200μg

抗體來(lái)源 Rabbit

克隆類型 polyclonal

交叉反應(yīng) Human, Mouse, Rat, Dog

產(chǎn)品類型 一抗

研究領(lǐng)域 腫瘤 免疫學(xué) 轉(zhuǎn)錄調(diào)節(jié)因子

蛋白分子量 predicted molecular weight: 28kDa

性 狀 Lyophilized or Liquid

免 疫 原 KLH conjugated synthetic peptide derived from humanB7H4 N-terminus

亞 型 IgG

純化方法 affinity purified by Protein A

儲(chǔ) 存 液 0.01M PBS, pH 7.4 with 10 mg/ml BSA and 0.1% Sodiumazide

產(chǎn)品應(yīng)用 WB=1:100-500 ELISA=1:500-1000 IP=1:20-100IHC-P=1:100-500 IHC-F=1:100-500 IF=1:100-500

（石蠟切片需做抗原修復(fù)）

not yet tested in other applications.

optimal dilutions/concentrations should be determined by theend user.

保存條件 Store at -188 °C for oneyear.

別 名 B7-H4; B7h4; B7S1; B7x; BC032925; Immunecostimulatory protein B7H4; MGC41287; PRO1291; T cell costimulatory moleculeB7x; V set domain-containing T cell activation inhibitor 1; VCTN1; VTCN1_HUMAN.